"When you breathe, think, laugh or lift your finger, your brain and nerves are communicating through electrical impulses transmitted by nerve cells. Neurology involves your entire nervous system -- the internal wiring that controls your body's function and movement. When an illness or injury disrupts the proper working of this complex system, chances are you'll need to see a neurologist. Your primary care provider will refer you to a neurologist who will provide principal care to patients with neurological disorders such as Parkinson’s disease, Alzheimer’s disease, multiple sclerosis or stroke."

During the past decade, Providence Medical Group-Medford Neurology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Providence Medical Group-Medford Neurology" #1 collaborator was "Pfizer" with 3 trials as a collaborator and "Mallinckrodt" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Providence Medical Group-Medford Neurology" are "Alzheimer's Disease" (3 trials), "Epilepsy With Partial On-set Seizures" (1 trials) and "Multiple Sclerosis, Relapsing-Remitting" (1 trials). Many other conditions were trialed in "Providence Medical Group-Medford Neurology" in a lesser frequency.

Most popular intervention types in "Providence Medical Group-Medford Neurology" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Bapineuzumab 0.5 mg/kg" (2 trials), "Bapineuzumab 1.0 m/kg" (2 trials), "Placebo Control" (2 trials), "ACTH" (1 trials) and "Bapineuzumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Providence Medical Group-Medford Neurology" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Providence Medical Group-Medford Neurology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Providence Medical Group-Medford Neurology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Providence Medical Group-Medford Neurology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".